Rajiv Agarwal

Publication Activity (10 Years)

Years Active: 2018-2023
Publications (10 Years): 47

Top Venues

Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association

Clinical journal of the American Society of Nephrology : CJASN

Diabetes, obesity & metabolism

Clinical kidney journal

Indiana University

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Indiana University

United States

Professor of Medicine :: Medicine

Publications

Rajiv Agarwal, Denis Fouque
The foundation and the four pillars of treatment for cardiorenal protection in people with chronic kidney disease and type 2 diabetes. Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 38 (2) (2023)
Rajiv Agarwal, Wanzhu F Tu, Alfredo E Farjat, Youssef M K Farag, Robert D Toto, Sanjay Kaul, Robert Lawatscheck, Katja Rohwedder, Luis M Ruilope, Ellen Burgess, Bertram Pitt, Gerasimos S Filippatos, Stefan D Anker, George L Bakris, null null
Impact of Finerenone-Induced Albuminuria Reduction on Chronic Kidney Disease Outcomes in Type 2 Diabetes : A Mediation Analysis. Annals of internal medicine (2023)
Janet B McGill, Rajiv Agarwal, Stefan D Anker, George L Bakris, Gerasimos Filippatos, Bertram Pitt, Luis M Ruilope, Andreas L Birkenfeld, Maria L Caramori, Meike Brinker, Amer Joseph, Andrea Lage, Robert Lawatscheck, Charlie Scott, Ellen Burgess, null null
Effects of finerenone in people with chronic kidney disease and type 2 diabetes are independent of HbA1c at baseline, HbA1c variability, diabetes duration and insulin use at baseline. Diabetes, obesity & metabolism (2023)
David Z I Cherney, Eleuterio Ferrannini, Guillermo E Umpierrez, Anne L Peters, Julio Rosenstock, David R Powell, Michael J Davies, Phillip Banks, Rajiv Agarwal
Efficacy and safety of sotagliflozin in patients with type 2 diabetes and stage 3 chronic kidney disease. Diabetes, obesity & metabolism (2023)
Robert A Fletcher, Clare Arnott, Patrick Rockenschaub, Aletta Elisabeth Schutte, Lewis Carpenter, Muthiah Vaduganathan, Rajiv Agarwal, George L Bakris, Tara I-Hsin Chang, Hiddo J Lambers Heerspink, Meg J Jardine, Kenneth W Mahaffey, Bruce C Neal, Carol A Pollock, Min Jun, Anthony Rodgers, Vlado Perkovic, Brendon L Neuen
Canagliflozin, Blood Pressure Variability, and Risk of Cardiovascular, Kidney, and Mortality Outcomes: Pooled Individual Participant Data From the CANVAS and CREDENCE Trials. Journal of the American Heart Association (2023)
Amy Kang, Brendan Smyth, Brendon L Neuen, Hiddo J Lambers Heerspink, Gian Luca Di Tanna, Hong Zhang, Clare Arnott, Carinna Hockham, Rajiv Agarwal, George L Bakris, David M Charytan, Dick de Zeeuw, Tom Greene, Adeera Levin, Carol Pollock, David C Wheeler, Kenneth W Mahaffey, Vlado Perkovic, Meg J Jardine
The sodium-glucose cotransporter-2 inhibitor canagliflozin does not increase risk of non-genital skin and soft tissue infections in people with type 2 diabetes mellitus: A pooled post hoc analysis from the CANVAS Program and CREDENCE randomized double-blind trials. Diabetes, obesity & metabolism (2023)
Brendon L Neuen, Hiddo J Lambers Heerspink, Priya Vart, Brian Lee Claggett, Robert A Fletcher, Clare Arnott, Juliana de Oliveira Costa, Michael O Falster, Sallie-Anne Pearson, Kenneth W Mahaffey, Bruce C Neal, Rajiv Agarwal, George L Bakris, Vlado Perkovic, Scott D Solomon, Muthiah Vaduganathan
Estimated Lifetime Cardiovascular, Kidney and Mortality Benefits of Combination Treatment With SGLT2 Inhibitors, GLP-1 Receptor Agonists, and Non-steroidal MRA Compared With Conventional Care in Patients With Type 2 Diabetes and Albuminuria. Circulation (2023)
Panagiotis I Georgianos, Rajiv Agarwal
Hypertension in chronic kidney disease - treatment standard 2023. Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association (2023)
Janet B McGill, Rajiv Agarwal, Stefan D Anker, George L Bakris, Gerasimos Filippatos, Bertram Pitt, Luis M Ruilope, Andreas L Birkenfeld, M Luiza Caramori, Meike Brinker, Amer Joseph, Andrea Lage, Robert Lawatscheck, Charlie Scott, Ellen Burgess, null null
Effects of finerenone in persons with CKD and T2D are independent of HbA1c at baseline, HbA1c variability, diabetes duration and insulin use at baseline. Diabetes, obesity & metabolism (2023)
David Z I Cherney, Eleuterio Ferrannini, Guillermo E Umpierrez, Anne L Peters, Julio Rosenstock, David R Powell, Michael J Davies, Phillip Banks, Rajiv Agarwal
Efficacy and Safety of Sotagliflozin in Patients With Type 2 Diabetes and Stage 3 Chronic Kidney Disease. Diabetes, obesity & metabolism (2023)
Rajiv Agarwal, Denis Fouque
The foundation and the four pillars of treatment for cardiorenal protection in people with chronic kidney disease and type 2 diabetes. Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 38 (2) (2023)
Rajiv Agarwal, Sibylle Jenny Hauske, David C Wheeler, Kent Doi, Amelie Elsaesser, Ivana Ritter, Dominik Steubl, Christoph Wanner
Empagliflozin and incidence of events consistent with acute kidney injury: Pooled safety analysis in more than 15 000 individuals. Diabetes, obesity & metabolism 24 (7) (2022)
Rajiv Agarwal, Bertram Pitt, Biff F Palmer, Csaba Pal Kovesdy, Ellen Burgess, Gerasimos Filippatos, Jolanta Małyszko, Luis M Ruilope, Patrick Rossignol, Ellen Burgess, Roberto Pecoits-Filho, Stefan D Anker, Amer Joseph, Robert Lawatscheck, Daniel Wilson, Martin Gebel, George L Bakris
A comparative post hoc analysis of finerenone and spironolactone in resistant hypertension in moderate-to-advanced chronic kidney disease. Clinical kidney journal 16 (2) (2022)
Jing-Wei Li, Clare Arnott, Hiddo J Lambers Heerspink, Qiang Li MBiostat, Christopher P Cannon, David C Wheeler, David M Charytan, Jennifer Barraclough, Gemma A Figtree, Rajiv Agarwal, George L Bakris, Dick de Zeeuw, Tom Greene, Adeera Levin, Carol A Pollock, Hong Zhang, Bernard Zinman, Kenneth W Mahaffey, Vlado Perkovic, Bruce C Neal, Meg J Jardine
Effect of Canagliflozin on Total Cardiovascular Burden in Patients With Diabetes and Chronic Kidney Disease: A Post Hoc Analysis From the CREDENCE Trial. Journal of the American Heart Association 11 (16) (2022)
Rajiv Agarwal, James Burton, Maurizio Gallieni, Kamyar Kalantar-Zadeh, Gert Mayer, Carol A Pollock, Jacek C Szepietowski
Alleviating symptoms in patients undergoing long-term hemodialysis: a focus on chronic kidney disease-associated pruritus. Clinical kidney journal 16 (1) (2022)
Rajiv Agarwal, Denis Fouque
The foundation and the four pillars of treatment for cardiorenal protection in people with chronic kidney disease and type 2 diabetes. Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association (2022)
Rajiv Agarwal
Should we CLICK on chlorthalidone for treatment-resistant hypertension in chronic kidney disease? Clinical kidney journal 16 (5) (2022)
Rajiv Agarwal, Arjun D Sinha, Wanzhu Tu
Chlorthalidone for Resistant Hypertension in Advanced Chronic Kidney Disease. Circulation 146 (9) (2022)
Brendon L Neuen, Megumi Oshima, Rajiv Agarwal, Clare Arnott, David Z I Cherney, Robert Edwards, Anna Maria Langkilde, Kenneth W Mahaffey, Darren K McGuire, Bruce C Neal, Vlado Perkovic, Annpey Pong, Marc S Sabatine, Itamar Raz, Tadashi Toyama, Christoph Wanner, David C Wheeler, Stephen D Wiviott, Bernard Zinman, Hiddo J Lambers Heerspink
Sodium-Glucose Cotransporter 2 Inhibitors and Risk of Hyperkalemia in People With Type 2 Diabetes: A Meta-Analysis of Individual Participant Data From Randomized, Controlled Trials. Circulation 145 (19) (2022)
Rajiv Agarwal
Should we CLICK on chlorthalidone for treatment-resistant hypertension in chronic kidney disease? Clinical kidney journal 16 (5) (2022)
Ellen Burgess, Rajiv Agarwal, Stefan D Anker, Gerasimos Filippatos, Bertram Pitt, Luis M Ruilope, Vivian A Fonseca, Guillermo E Umpierrez, Maria Luiza Caramori, Amer Joseph, Marc Lambelet, Robert Lawatscheck, George L Bakris, null null
Finerenone in patients across the spectrum of chronic kidney disease and type 2 diabetes by glucagon-like peptide-1 receptor agonist use. Diabetes, obesity & metabolism (2022)
Panagiotis I Georgianos, Rajiv Agarwal
Advances in the area of cardiorenal medicine: clinical research highlights from selected papers published in NDT. Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 37 (9) (2022)
Panagiotis I Georgianos, Rajiv Agarwal
The non-steroidal MRA finerenone in cardiorenal medicine: a state-of-the-art review of the literature. American journal of hypertension (2022)
Rajiv Agarwal, Gerasimos Filippatos, Bertram Pitt, Stefan D Anker, Ellen Burgess, Amer Joseph, Peter Kolkhof, Christina Nowack, Martin Gebel, Luis M Ruilope, George L Bakris, null null
Cardiovascular and kidney outcomes with finerenone in patients with type 2 diabetes and chronic kidney disease: the FIDELITY pooled analysis. European heart journal 43 (6) (2022)
Rajiv Agarwal
Hydrochlorothiazide Versus Chlorthalidone: What Is the Difference? Circulation 146 (22) (2022)
David M Charytan, Jie Yu, Meg J Jardine, Christopher P Cannon, Rajiv Agarwal, George Bakris, Tom Greene, Adeera Levin, Carol Pollock, Neil R Powe, Clare Arnott, Kenneth W Mahaffey, null null
Potential Effects of Elimination of the Black Race Coefficient in eGFR Calculations in the CREDENCE Trial. Clinical journal of the American Society of Nephrology : CJASN 17 (3) (2022)
Bradley A Warady, Pablo E Pergola, Rajiv Agarwal, Sharon Andreoli, Gerald B Appel, Sripal Bangalore, Geoffrey A Block, Arlene B Chapman, Melanie P Chin, Keisha L Gibson, Angie Goldsberry, Kazumoto Iijima, Lesley A Inker, Clifford E Kashtan, Bertrand Knebelmann, Laura H Mariani, Colin J Meyer, Kandai Nozu, Megan O'Grady, Michelle N Rheault, Arnold L Silva, Peter Stenvinkel, Roser Torra, Glenn M Chertow
Effects of Bardoxolone Methyl in Alport Syndrome. Clinical journal of the American Society of Nephrology : CJASN (2022)
Rajiv Agarwal, Bertram Pitt, Biff F Palmer, Csaba Pal Kovesdy, Ellen Burgess, Gerasimos Filippatos, Jolanta Małyszko, Luis M Ruilope, Patrick Rossignol, Ellen Burgess, Roberto Pecoits-Filho, Stefan D Anker, Amer Joseph, Robert Lawatscheck, Daniel Wilson, Martin Gebel, George L Bakris
A comparative post hoc analysis of finerenone and spironolactone in resistant hypertension in moderate-to-advanced chronic kidney disease. Clinical kidney journal 16 (2) (2022)
Luis M Ruilope, Rajiv Agarwal, Stefan D Anker, Gerasimos S Filippatos, Bertram Pitt, Ellen Burgess, Pantelis A Sarafidis, Roland Erich Schmieder, Amer Joseph, Nicole Mentenich, Christina Nowack, George L Bakris, null null
Blood Pressure and Cardiorenal Outcomes With Finerenone in Chronic Kidney Disease in Type 2 Diabetes. Hypertension (Dallas, Tex. : 1979) 79 (12) (2022)
Rajiv Agarwal, James Burton, Maurizio Gallieni, Kamyar Kalantar-Zadeh, Gert Mayer, Carol A Pollock, Jacek C Szepietowski
Alleviating symptoms in patients undergoing long-term hemodialysis: a focus on chronic kidney disease-associated pruritus. Clinical kidney journal 16 (1) (2022)
Rajiv Agarwal, Arjun D Sinha, Andrew E Cramer, Mary Balmes-Fenwick, Jazmyn H Dickinson, Fangqian Ouyang, Wanzhu Tu
Chlorthalidone for Hypertension in Advanced Chronic Kidney Disease. The New England journal of medicine (2021)
Rajiv Agarwal, Patrick Rossignol, Jeffrey Budden, Martha R Mayo, Susan Arthur, Bryan Williams, William B White
Patiromer and Spironolactone in Resistant Hypertension and Advanced CKD: Analysis of the Randomized AMBER Trial. Kidney360 2 (3) (2021)
Rajiv Agarwal, Wanzhu Tu
NIH Funding, Research Productivity, and Scientific Impact: a 20-Year Study. Journal of general internal medicine (2021)
Rajiv Agarwal, Patrick Rossignol, Martha R Mayo, Ansgar Conrad, Susan Arthur, Bryan Williams, William B White
Patiromer to Enable Spironolactone in Patients with Resistant Hypertension and CKD (AMBER): Results in the Prespecified Subgroup with Diabetes. Clinical journal of the American Society of Nephrology : CJASN 16 (9) (2021)
Patrick Rossignol, Rajiv Agarwal
Should renin-angiotensin-aldosterone system inhibition enablement be a therapeutic target in CKD patients? Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 36 (10) (2021)
Brendon L Neuen, Megumi Oshima, Vlado Perkovic, Rajiv Agarwal, Clare Arnott, George L Bakris, Christopher P Cannon, David M Charytan, Robert Edwards, Jose Luis Gorriz Teruel, Meg J Jardine, Adeera Levin, Bruce C Neal, Luca De Nicola, Carol A Pollock, Norman Rosenthal, David C Wheeler, Kenneth W Mahaffey, Hiddo J L Heerspink
Effects of canagliflozin on serum potassium in people with diabetes and chronic kidney disease: the CREDENCE trial. European heart journal (2021)
Rajiv Agarwal, Stefan D Anker, Gerasimos Filippatos, Bertram Pitt, Ellen Burgess, Luis M Ruilope, John Boletis, Robert Toto, Guillermo E Umpierrez, Christoph Wanner, Takashi Wada, Charlie Scott, Amer Joseph, Ike Ogbaa, Luke Roberts, Markus F Scheerer, George L Bakris
Effects of canagliflozin versus finerenone on cardiorenal outcomes: exploratory post-hoc analyses from FIDELIO-DKD compared to reported CREDENCE results. Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association (2021)
Gerasimos S Filippatos, Stefan D Anker, Rajiv Agarwal, Luis M Ruilope, Peter Rossing, George L Bakris, Christoph Tasto, Amer Joseph, Peter Kolkhof, Andrea Lage, Bertram Pitt, null null
Finerenone Reduces Risk of Incident Heart Failure in Patients With Chronic Kidney Disease and Type 2 Diabetes: Analyses from the FIGARO-DKD Trial. Circulation (2021)
Rajiv Agarwal
Spironolactone and chlorthalidone-old drugs, new uses-but approach with caution. Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association (2021)
Meg Jardine, Zien Zhou, Hiddo J Lambers Heerspink, Carinna Hockham, Qiang Li, Rajiv Agarwal, George L Bakris, Christopher P Cannon, David M Charytan, Tom Greene, Adeera Levin, Jing-Wei Li, Brendon L Neuen, Bruce C Neal, Richard Oh, Megumi Oshima, Carol Pollock, David C Wheeler, Dick de Zeeuw, Hong Zhang, Bernard Zinman, Kenneth W Mahaffey, Vlado Perkovic
Kidney, Cardiovascular, and Safety Outcomes of Canagliflozin according to Baseline Albuminuria: A CREDENCE Secondary Analysis. Clinical journal of the American Society of Nephrology : CJASN 16 (3) (2021)
Rajiv Agarwal
Much to Fear about MUCH. Journal of the American Society of Nephrology : JASN 31 (11) (2020)
Panagiotis I Georgianos, Rajiv Agarwal
Ambulatory BP Phenotypes and Their Association with Target Organ Damage and Clinical Outcomes in CKD. Clinical journal of the American Society of Nephrology : CJASN 15 (4) (2020)
Panagiotis I Georgianos, Rajiv Agarwal
Can We Mend the Broken Clock by Timing Antihypertensive Therapy Sensibly? Clinical journal of the American Society of Nephrology : CJASN 15 (10) (2020)
Panagiotis I Georgianos, Rajiv Agarwal
Prevention of intradialytic hypotensive episodes: is setraline an effective pharmacological approach? Jornal brasileiro de nefrologia : 'orgao oficial de Sociedades Brasileira e Latino-Americana de Nefrologia 41 (4) (2020)
Panagiotis I Georgianos, Rajiv Agarwal
Ambulatory Blood Pressure Reduction With SGLT-2 Inhibitors: Dose-Response Meta-analysis and Comparative Evaluation With Low-Dose Hydrochlorothiazide. Diabetes care 42 (4) (2019)
Vasilios Vaios, Panagiotis I Georgianos, Vassilios Liakopoulos, Rajiv Agarwal
Assessment and Management of Hypertension among Patients on Peritoneal Dialysis. Clinical journal of the American Society of Nephrology : CJASN 14 (2) (2018)
Arjun D Sinha, Rajiv Agarwal
Clinical Pharmacology of Antihypertensive Therapy for the Treatment of Hypertension in CKD. Clinical journal of the American Society of Nephrology : CJASN 14 (5) (2018)

Rajiv Agarwal.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Rajiv Agarwal